KMDA
Price
$7.72
Change
-$0.06 (-0.77%)
Updated
Jul 25 closing price
Capitalization
306.49M
17 days until earnings call
SIGA
Price
$7.14
Change
+$0.08 (+1.13%)
Updated
Jul 25 closing price
Capitalization
608.54M
4 days until earnings call
Interact to see
Advertisement

KMDA vs SIGA

Header iconKMDA vs SIGA Comparison
Open Charts KMDA vs SIGABanner chart's image
Kamada
Price$7.72
Change-$0.06 (-0.77%)
Volume$18.11K
Capitalization306.49M
SIGA Technologies
Price$7.14
Change+$0.08 (+1.13%)
Volume$286.9K
Capitalization608.54M
KMDA vs SIGA Comparison Chart in %
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. SIGA commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a Hold and SIGA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (KMDA: $7.72 vs. SIGA: $7.14)
Brand notoriety: KMDA and SIGA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 27% vs. SIGA: 79%
Market capitalization -- KMDA: $306.49M vs. SIGA: $608.54M
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. SIGA’s [@Pharmaceuticals: Other] market capitalization is $608.54M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 0 FA rating(s) are green whileSIGA’s FA Score has 1 green FA rating(s).

  • KMDA’s FA Score: 0 green, 5 red.
  • SIGA’s FA Score: 1 green, 4 red.
According to our system of comparison, SIGA is a better buy in the long-term than KMDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 4 TA indicator(s) are bullish while SIGA’s TA Score has 4 bullish TA indicator(s).

  • KMDA’s TA Score: 4 bullish, 4 bearish.
  • SIGA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both KMDA and SIGA are a good buy in the short-term.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а +3.62% price change this week, while SIGA (@Pharmaceuticals: Other) price change was +8.02% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

KMDA is expected to report earnings on Aug 13, 2025.

SIGA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SIGA($609M) has a higher market cap than KMDA($306M). KMDA has higher P/E ratio than SIGA: KMDA (37.43) vs SIGA (9.24). SIGA (31.199) and KMDA (30.397) have similar YTD gains . SIGA has higher annual earnings (EBITDA): 84.2M vs. KMDA (22.4M). SIGA has more cash in the bank: 150M vs. KMDA (55.6M). SIGA has less debt than KMDA: SIGA (564K) vs KMDA (8.82M). KMDA (143M) and SIGA (140M) have equivalent revenues.
KMDASIGAKMDA / SIGA
Capitalization306M609M50%
EBITDA22.4M84.2M27%
Gain YTD30.39731.19997%
P/E Ratio37.439.24405%
Revenue143M140M102%
Total Cash55.6M150M37%
Total Debt8.82M564K1,564%
FUNDAMENTALS RATINGS
KMDA vs SIGA: Fundamental Ratings
KMDA
SIGA
OUTLOOK RATING
1..100
6978
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
9583
SMR RATING
1..100
8038
PRICE GROWTH RATING
1..100
4847
P/E GROWTH RATING
1..100
4634
SEASONALITY SCORE
1..100
5028

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (1) in the Pharmaceuticals Other industry is significantly better than the same rating for KMDA (71) in the Biotechnology industry. This means that SIGA’s stock grew significantly faster than KMDA’s over the last 12 months.

SIGA's Profit vs Risk Rating (83) in the Pharmaceuticals Other industry is in the same range as KMDA (95) in the Biotechnology industry. This means that SIGA’s stock grew similarly to KMDA’s over the last 12 months.

SIGA's SMR Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for KMDA (80) in the Biotechnology industry. This means that SIGA’s stock grew somewhat faster than KMDA’s over the last 12 months.

SIGA's Price Growth Rating (47) in the Pharmaceuticals Other industry is in the same range as KMDA (48) in the Biotechnology industry. This means that SIGA’s stock grew similarly to KMDA’s over the last 12 months.

SIGA's P/E Growth Rating (34) in the Pharmaceuticals Other industry is in the same range as KMDA (46) in the Biotechnology industry. This means that SIGA’s stock grew similarly to KMDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDASIGA
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
66%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 9 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSPKX23.390.17
+0.73%
Victory RS Partners R
CPTUX92.300.56
+0.61%
Invesco Discovery Large Cap R5
DHIYX20.340.02
+0.10%
Diamond Hill International Y
FIIAX22.85N/A
N/A
Fidelity Advisor Mid Cap II A
NSFMX7.31N/A
N/A
Natixis Target Retirement 2060 N

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and OGI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
-0.77%
OGI - KMDA
30%
Poorly correlated
+1.32%
RDY - KMDA
28%
Poorly correlated
+0.36%
AMRX - KMDA
27%
Poorly correlated
+0.75%
PAHC - KMDA
25%
Poorly correlated
-0.88%
ELAN - KMDA
25%
Poorly correlated
+1.57%
More

SIGA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIGA has been loosely correlated with EBS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SIGA jumps, then EBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGA
1D Price
Change %
SIGA100%
+1.13%
EBS - SIGA
34%
Loosely correlated
-4.02%
OGI - SIGA
28%
Poorly correlated
+1.32%
CURR - SIGA
26%
Poorly correlated
+3.15%
AMRX - SIGA
25%
Poorly correlated
+0.75%
KMDA - SIGA
24%
Poorly correlated
-0.77%
More